Healthcare provider profile · identity verified

William Moore

Nurse Practitioner · WEST MONROE, LA · NPI 1487092276

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	240	82
Levothyroxine Sodium	Levothyroxine Sodium	240	74
Omeprazole	Omeprazole	234	74
Gabapentin	Gabapentin	224	67
Lisinopril	Lisinopril	216	68
Atorvastatin Calcium	Atorvastatin Calcium	176	61
Metformin Hcl	Metformin Hcl	176	54
Losartan Potassium	Losartan Potassium	174	53
Prednisone	Prednisone	172	102
Clonazepam	Clonazepam	140	30
Pantoprazole Sodium	Pantoprazole Sodium	140	51
Furosemide	Furosemide	128	55
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	124	97
Hydrochlorothiazide	Hydrochlorothiazide	106	42
Metoprolol Succinate	Metoprolol Succinate	102	40
Metoprolol Tartrate	Metoprolol Tartrate	98	35
Montelukast Sodium	Montelukast Sodium	97	37
Potassium Chloride	Potassium Chloride	86	33
Tamsulosin Hcl	Tamsulosin Hcl	79	26
Tizanidine Hcl	Tizanidine Hcl	77	26
Doxycycline Hyclate	Doxycycline Hyclate	75	58
Meloxicam	Meloxicam	74	30
Cefuroxime	Cefuroxime Axetil	72	60
Clopidogrel	Clopidogrel Bisulfate	71	23
Eliquis	Apixaban	71	13
Pravastatin Sodium	Pravastatin Sodium	69	22
Trazodone Hcl	Trazodone Hcl	65	21
Jardiance	Empagliflozin	64	14
Ozempic	Semaglutide	62	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	62	18
Albuterol Sulfate Hfa	Albuterol Sulfate	60	28
Azithromycin	Azithromycin	60	51
Tramadol Hcl	Tramadol Hcl	58	31
Escitalopram Oxalate	Escitalopram Oxalate	57	20
Fluconazole	Fluconazole	57	37
Duloxetine Hcl	Duloxetine Hcl	52	18
Fluticasone Propionate	Fluticasone Propionate	48	25
Azelastine Hcl	Azelastine Hcl	46	30
Mounjaro	Tirzepatide	45	suppressed
Simvastatin	Simvastatin	45	17
Zolpidem Tartrate	Zolpidem Tartrate	42	11
Ondansetron Odt	Ondansetron	41	26
Glimepiride	Glimepiride	40	12
Nifedipine Er	Nifedipine	39	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	29
Lorazepam	Lorazepam	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	28
Diazepam	Diazepam	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Amoxicillin	Amoxicillin	33	27
Mupirocin	Mupirocin	32	23
Allopurinol	Allopurinol	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	11
Carvedilol	Carvedilol	30	suppressed
Famotidine	Famotidine	29	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	28	11
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Glyxambi	Empagliflozin/Linagliptin	27	suppressed
Methocarbamol	Methocarbamol	27	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	12
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Finasteride	Finasteride	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	12
Lovastatin	Lovastatin	23	suppressed
Temazepam	Temazepam	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	14
Diclofenac Sodium	Diclofenac Sodium	21	14
Ezetimibe	Ezetimibe	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Estradiol	Estradiol	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Warfarin Sodium	Warfarin Sodium	18	suppressed
Atenolol	Atenolol	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Cefdinir	Cefdinir	16	12
Chlorthalidone	Chlorthalidone	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Glipizide	Glipizide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	11
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Linzess	Linaclotide	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error